Considerations for physiologically based pharmacokinetic and pharmacodynamic (PBPK-PD) modeling to facilitate drug development in obese and related specific populations
Combining aggregate and individual level data – opportunities and considerations Session title: High-impact Applications of Model-based Meta-analyses (MBMA) in Drug Development